In addition, researchers characterized a new subpopulation of naturally occurring CD4+ and CD8+ T cells expressing HLA-G (HLA-Gpos Treg) in the peripheral blood of MS relapsing patients, showing inhibitory effects through HLA-G5 secretion and sHLA release-G1 [60,90]. This evidence concerns the gene HLA-G and myeloid sarcoma.